Citation: Wf. Lee et Wy. Yuan, Thermoreversible hydrogels XI: Effect of salt on the swelling properties of the (N-isopropylacrylamide-co-sodium 2-acrylamido-2-methylpropyl sulfonate) copolymeric hydrogels, J APPL POLY, 79(9), 2001, pp. 1675-1684
Citation: Wf. Lee et Wy. Yuan, Thermoreversible hydrogels X: Synthesis and swelling behavior of the (N-isopropylacrylamide-co-sodium 2-acrylamido-2-methylpropyl sulfonate) copolymeric hydrogels, J APPL POLY, 77(8), 2000, pp. 1760-1768
Authors:
Morrison, BW
Fricke, J
Brown, J
Yuan, WY
Kotey, P
Mehlisch, D
Citation: Bw. Morrison et al., The optimal analgesic dose of rofecoxib: Overview of six randomized controlled trials, J AM DENT A, 131(12), 2000, pp. 1729-1737
Authors:
Gottesdiener, K
Mehlisch, DR
Huntington, M
Yuan, WY
Brown, P
Gertz, B
Mills, S
Citation: K. Gottesdiener et al., Efficacy and tolerability of the specific cyclooxygenase-2 inhibitor DFP compared with naproxen sodium in patients with postoperative dental pain, CLIN THER, 21(8), 1999, pp. 1301-1312
Authors:
Morrison, BW
Christensen, S
Yuan, WY
Brown, J
Amlani, S
Seidenberg, B
Citation: Bw. Morrison et al., Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib inpost-dental surgery pain: A randomized, controlled trial, CLIN THER, 21(6), 1999, pp. 943-953
Authors:
Ehrich, EW
Dallob, A
De Lepeleire, I
Van Hecken, A
Riendeau, D
Yuan, WY
Porras, A
Wittreich, J
Seibold, JR
De Schepper, P
Mehlisch, DR
Gertz, BJ
Citation: Ew. Ehrich et al., Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model, CLIN PHARM, 65(3), 1999, pp. 336-347
Citation: Wy. Yuan et al., Introduction of multi-alien chromatins carrying different powdery mildew-resistant genes from rye and Haynaldia villosa into wheat genome, GENE GEN SY, 73(6), 1998, pp. 377-384